期刊文献+

丽珠得乐治疗消化性溃疡的疗效观察

Effects of Bismuth Potassium Citrate Granules on Peptic Ulcers
下载PDF
导出
摘要 目的:探讨丽珠得乐治疗消化性溃疡的临床疗效。方法:将62例消化性溃疡患者随机分为两组:观察组33例和对照组29例。观察组采用丽珠得乐220mg,口服,2次/d,阿莫西林500mg,口服,2次/d,呋喃唑酮100mg,口服,2次/d,雷尼替丁150mg,口服,2次/d,疗程为2周;对照组采用硫糖铝1000mg,口服,3次/d,阿莫西林500mg,口服,2次/d,呋喃唑酮100mg,口服,2次/d,雷尼替丁150mg,口服,2次/d,疗程为2周。观察两组疗程结束后1周和2周时主要症状的消失率及疗程结束后2周时复查胃镜示溃疡愈合情况。结果:观察组疗程结束后1周时腹痛消失率、反酸消失率分别为62.5%、63.3%高于对照组的50.0%、53.8%(P均<0.05);观察组疗程结束后2周时腹痛消失率、反酸消失率、胃镜复查溃疡愈合总有效率分别为87.5%、86.7%、75.7%明显高于对照组的67.8%、69.2%、55.2%(P均<0.05)。结论:丽珠得乐作为胃粘膜保护剂治疗消化性溃疡效果优于硫糖铝。 Objective:To observe the effectiveness of bismuth potassium citrate granules treatment for peptic ulcers. Methods:Sixty-two patients with peptic ulcer were randomly divided into two groups: observation group (n = 33 ) [ gastric ulcer ( n = 7 ) and duodenal ulcer ( n = 26 ) ] were treated with bismuth potassium citrate granules 220 g bid+Amoxicillin 500 mg bid+furazolidone 100 mg bid + ranitidine 150 mg bid for two weeks. The control group (n = 29) [gastric ulcer(n= 6) and duodenal ulcer(n=23)]were treated with sucralfate tablets 1000 mg tid+Amoxicillin 500 mg bid+ furazolidone 100 mg bid+ ranitidine 150 mg bid for two weeks. The disappearance rates of the main symptom were detected at one week and two weeks after treatment and re-astroscopy was performed at two weeks after treatment. Results: The disappearance rates of abdominal pain and brash in the observation group (62.5% and63.3%)were higher than those in the control group (50.0%and53.8 %)(P〈0.05, respectively)at one week after treatment. At two weeks after treatment, the disappearance rates of abdominal pain and brash and the total effective healing rate of ulcer in the observation group (87.5%,86.7%and75.7%) were significantly higher than those in the control group(67.8%,69.2%and55.2%)(P〈0.05, respectively). Conclusion:As a gastricmucosa-protection agent, the effectiveness of bismuth potassium citrate granules treatment for peptic ulcer is more effective than sucralfate.
作者 宋振其
出处 《实用临床医学(江西)》 CAS 2005年第9期38-40,共3页 Practical Clinical Medicine
关键词 丽珠得乐 硫糖铝 消化性溃疡 治疗 bismuth potassium citrate granules sucralfate peptic ulcer treatment
  • 相关文献

参考文献3

二级参考文献12

  • 1Howden CW, Hunt RH. Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol, 1998, 93: 2330--2338.
  • 2Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G.Current concepts in the management of Helicobacter pylori infection -- the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther, 2002,16: 167-- 180.
  • 3Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol, 1998, 13: 1--12.
  • 4Hunt RH, Fallone CA, Thomson AB. Canadian Helicobacter pylori Consensus Conference update:infections in adults. Canadian Helicobacter Study Group. Can J Gastroenterol, 1999, 13: 213--217.
  • 5Sharma VK, Vasudeva R, Howden CW. A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection. Am J Gastroenterol, 1999, 94: 3170--3174.
  • 6O'Connor HJ. Helicobacter pylori and dyspepsia:physicians' attitudes, clinical practice, and prescribing habits. Aliment Pharmacol Ther, 2002,16: 487--496.
  • 7Breuer T, Sudhop T, Goodman KJ, Graham DY,Malfertheiner P. How do practicing clinicians manage Helicobacter pylori-related gastrointestinal diseases in Germany? A survey of gastroen-terologists and family practitioners. Helicobacter,1998. 3: 1--8.
  • 8MacOni G, Tosetti C, Miroglio G, Parente F, Colombo E, Sainaghi M, Bianchi Porro G. Management of Helicobacter pylori-related gastrointestinal diseases by general practitioners in Italy. Aliment Pharmacol Ther, 1999, 13: 1499--1504.
  • 9Binek J, Fantin AC, Meyenberger C. Attitude to Helicobacter pylori infection among Swiss gastroenterologists. Schweiz Med Wochenschr, 1999,129:441--445.
  • 10Xiao SD, Liu WZ, Hu PJ, Ouyang Q, Wang JL,Zhou LY, Cheng NN. A multicentre study on eradication of Helicobacter priori using four 1-week triple therapies in China. Aliment Pharmacol Ther. 2001.15: 81--86.

共引文献326

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部